Article Type

406 - 420 of 1459 Results       Clear All

Scientists Explain What We Should Expect as COVID Variants Xbb, Bq.1 Spread in Europe, Asia

Gladstone in the News October 20, 2022

Scientists Explain What We Should Expect as COVID Variants Xbb, Bq.1 Spread in Europe, Asia

ABC7 News—Senior Investigator Nadia Roan, PhD, says that a winter surge of infections from the highly transmissible new variants of SARS-CoV-2 currently emerging in the US is likely, but it remains unclear how bad it will be.

Gladstone Experts COVID-19 Infectious Disease Roan Lab

Hereditary Disease Foundation Announces 2022 Prize Winners for Leadership in Huntington’s Disease Research

Gladstone in the News October 19, 2022

Hereditary Disease Foundation Announces 2022 Prize Winners for Leadership in Huntington’s Disease Research

Global News Wire—Gladstone Investigator Steve Finkbeiner was awarded the 2022 Leslie Gehry Prize for Innovation in Science. The award recognizes his advancements in developing novel technologies, such as robotic microscopy and deep learning pipelines, that can be used to understand and develop treatments for Huntington’s disease.

Gladstone Experts Huntington’s Disease Center for Systems and Therapeutics Taube-Koret Center for Neurodegenerative Disease Research Finkbeiner Lab Robotic Microscopy

National Academy of Medicine Elects 100 New Members

Gladstone in the News October 17, 2022

National Academy of Medicine Elects 100 New Members

National Academy of Medicine—Katie Pollard, PhD, senior investigator and director of the Gladstone Institute of Data Science and Biotechnology, has been elected to the National Academy of Medicine, in recognition of her discovery of fast-evolving regions in the human genome associated with psychiatric diseases, and of her open-source software used worldwide by genome scientists.

Gladstone Experts Data Science and Biotechnology Pollard Lab Big Data Genomics Human Genetics Microbiome

How Long Does Immunity from the New COVID Bivalent Boosters Last ’in the Real World’?

Gladstone in the News October 16, 2022

How Long Does Immunity from the New COVID Bivalent Boosters Last ’in the Real World’?

San Francisco Chronicle—The new bivalent COVID-19 booster shots are recommended for individuals age 5 and up who are at least two months past their last vaccine dose. Gladstone Investigator Nadia Roan explains that the bivalent boosters greatly increase the levels of antibodies that can prevent the Omicron variant from infecting cells.

Gladstone Experts COVID-19 Infectious Disease Roan Lab

When’s the Best Time to Get the New COVID Booster Shot? Here’s What Experts Say

Gladstone in the News September 10, 2022

When’s the Best Time to Get the New COVID Booster Shot? Here’s What Experts Say

San Francisco Chronicle—New COVID-19 booster shots targeting both the ancestral virus and omicron strains are now available. Gladstone Investigator Nadia Roan weighs in on when people should get the jab, based on the timing of their last dose and whether they’ve been recently infected.

Gladstone Experts COVID-19 Infectious Disease Roan Lab

More News

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media